Cardiff Oncology (CRDF)Director bought ~$37K
Gary W Pace, Director at Cardiff Oncology, bought ~$37K of Cardiff Oncology shares.
- ~$37K
- Approx. value · 30K sh @ $1.22
- 1.36M
- Holds after · shares reported
- Traded
- Jun 18, 2026
- Filed
- Jun 22, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 14, 2026Company filing · Form 8-K · ResultsReported its results
- May 27, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Jun 18, 2026 · this disclosureInsiderDirector purchased ~$37K of CRDF shares in the open market
What came next
- Jun 18, 2026Insider · Their first buy on recordCEO purchased ~$30K of CRDF shares in the open market
- Jul 14, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
- Jul 14, 2026Insider · 2 peopleInsiders: 2 purchases (~$1.0M)
- Aug 11, 2026Company filing · Form 8-K · ResultsReported its results
- Sep 14, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Cardiff Oncology
For Cardiff Oncology, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRDF page.
Other recent filings by Gary W Pace, Director
- SEC Form 4 at Cardiff Oncology (CRDF)Jul 16, 2026
- SEC Form 4 at Cardiff Oncology (CRDF)Jul 31, 2025
- SEC Form 4 at Cardiff Oncology (CRDF)Jul 31, 2025
- SEC Form 4 at Cardiff Oncology (CRDF)Dec 12, 2024
- SEC Form 4 at Cardiff Oncology (CRDF)Dec 12, 2024
The full history of Gary W Pace, Director is on the profile page.
How this filing works
Other disclosures at Cardiff Oncology
- SEC Form 4Jul 16, 2026
- SEC Form 4Jul 16, 2026
- SEC Form 4Jun 22, 2026
- SEC Form 4Jul 31, 2025
- SEC Form 4Jul 31, 2025
- SEC Form 4Dec 18, 2024
Everything OQRO holds on this company is on its CRDF page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
